TruelJS, WangCX, SchlessingerDI, et al.Cetrimonium bromide patch test positivity is found with a high frequency in a cohort of patients with frontal fibrosing alopecia. Dermatitis®, 2024; 35(1):100–101; doi: 10.1089/derm.2022.0086
2.
PrasadS, MarksDH, BurnsLJ, et al.Patch testing and contact allergen avoidance in patients with lichen planopilaris and/or frontal fibrosing alopecia: a cohort study. J Am Acad Dermatol, 2020; 83(2):659–661; doi: 10.1016/j.jaad.2020.01.026
3.
KarimM, KleinEJ, NohriaA, et al.Potential for allergic contact Dermatitis® in popular hair care practices and ingredients. Dermatitis®, 2023; 34(6):484–491; doi: 10.1089/derm.2023.0045
4.
PangS, WillisL, AndersenFA. Final report on the safety assessment of cetrimonium chloride, cetrimonium bromide, and steartrimonium chloride. Int J Toxicol, 1997; 16(3):195–220; doi: 10.1080/109158197227152
5.
BeckerLC, BergfeldWF, BelsitoDV, et al.Safety assessment of trimoniums as used in cosmetics. Int J Toxicol, 2012; 31(6 Suppl):296S–341S; doi: 10.1177/1091581812467378
6.
AldooriN, DobsonK, HoldenCR, et al.Frontal fibrosing alopecia: possible association with leave-on facial skin care products and sunscreens; a questionnaire study. Br J Dermatol, 2016; 175(4):762–767; doi: 10.1111/bjd.14535
7.
RochaVB, DonatiA, ContinLA, et al.Photopatch and patch testing in 63 patients with frontal fibrosing alopecia: a case series. Br J Dermatol, 2018; 179(6):1402–1403; doi: 10.1111/bjd.16933
8.
DeKovenJG, WarshawEM, ZugKA, et al.North American contact Dermatitis® group patch test results: 2015–2016. Dermatitis®, 2018; 29(6):297–309; doi: 10.1097/DER.0000000000000417
9.
ShtaynbergerB, BruderP, ZippinJH. The prevalence of type IV hypersensitivity in patients with lichen planopilaris and frontal fibrosing alopecia. Dermatitis®, 2023; 34(4):351–352; doi: 10.1097/DER.0000000000000965
10.
Brunet-PossentiF, DeschampsL, ColbocH, et al.Detection of titanium nanoparticles in the hair shafts of a patient with frontal fibrosing alopecia. J Eur Acad Dermatol Venereol, 2018; 32(12):e442–e443; doi: 10.1111/jdv.14967
11.
BoydAS. Dermal titanium dioxide deposits in frontal fibrosing alopecia—a pilot study. J Clin Med Img, 1994; 6(24):1–2.
12.
MattaMK, ZusterzeelR, PilliNR, et al.Effect of sunscreen application under maximal use conditions on plasma concentration of sunscreen active ingredients: A randomized clinical trial. JAMA, 2019; 321(21):2082–2091; doi: 10.1001/jama.2019.5586
13.
RobinsonG, McMichaelA, WangSQ, et al.Sunscreen and frontal fibrosing alopecia: A review. J Am Acad Dermatol, 2020; 82(3):723–728; doi: 10.1016/J.JAAD.2019.09.085
